title: The Use of PET in Radiation Therapy for Lymphoma.
abstract: Positron emission tomography (PET) with 18-fluorodeoxyglucose (FDG) and computed tomography (CT) has essentially replaced CT alone for staging of lymphomas. FDG-PET has been incorporated into the revised response criteria, but response adapted strategies are still being evaluated. The role of FDG-PET/CT in radiation treatment planning is still being developed. It is unclear how to use FDG-PET/CT to determine whether to give consolidative radiation, where to radiate, and what dose. Ongoing efforts are underway to use early interim FDG-PET/CT to limit therapy in good prognosis patients. A multidisciplinary team is important in the management of patients with lymphoma, leading to individualized treatment plans and better outcomes.
authors.affiliation: Department of Radiation Oncology, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
authors.forename: John P
authors.initials: JP
authors.lastname: Plastaras
authors.affiliation: Department of Radiation Oncology, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
authors.forename: Geoffrey
authors.initials: G
authors.lastname: Geiger
authors.affiliation: Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, University of Pennsylvania, 3400 Spruce Street, Donner 110-B, Philadelphia, PA 19104, USA; Division of Hematology and Oncology, Department of Medicine, University of Pennsylvania, 3400 Spruce Street, Donner 110-B, Philadelphia, PA 19104, USA.
authors.forename: Rodolfo
authors.initials: R
authors.lastname: Perini
authors.affiliation: Department of Radiation Oncology, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
authors.forename: Eli
authors.initials: E
authors.lastname: Glatstein